Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Merus NV MRUS

Healthcare Biotechnology
Merus NV is the Netherlands - based biotechnology company, concentrated on developing differentiating therapeutics for cancer patients. The product programs in the Merus pipeline are based on the Multiclonics format. Its products are designed to bind to multiple targets, and are manufactured with features for anti-cancer effects against the complex mechanisms that drive cancer. Company's... see more

Recent & Breaking News (NDAQ:MRUS)

Merus Announces Closing of Global Strategic Research Collaboration with Incyte to Discover and Develop Bispecific Antibodies

GlobeNewswire January 23, 2017

Merus and the Institute for Research in Biomedicine (IRB) Barcelona Form Research Collaboration to Develop Bispecific Antibodies Targeting the Tumor Microenvironment

GlobeNewswire January 5, 2017

18 Biggest Mid-Day Gainers For Wednesday

Benzinga.com  January 4, 2017

Merus NV Executives Discuss Products And Plans Going Into 2017: 'We Have Milestones Coming Up'

Benzinga.com  December 23, 2016

Mid-Afternoon Market Update: Crude Oil Down 1.5%; Merus Shares Spike Higher

Benzinga.com  December 21, 2016

Mid-Morning Market Update: Markets Edge Lower; Finish Line Misses Q3 Expectations

Benzinga.com  December 21, 2016

20 Stocks Moving In Wednesday's Pre-Market Session

Benzinga.com  December 21, 2016

Incyte and Merus Announce Global Strategic Research Collaboration to Discover and Develop Bispecific Antibodies

Business Wire December 21, 2016

Merus Announces Favorable Decisions in Europe and Japan for Patents Covering Genetically-Modified Mice for Common Light Chain Human Monoclonal Antibodies

GlobeNewswire November 15, 2016

Merus to Present at the Jefferies London Healthcare Conference

GlobeNewswire November 10, 2016

Merus N.V. Receives €1.5 Million EUREKA Eurostars Grant with Aquila BioMedical Ltd to Jointly Develop Immunological Assays for Identification of Novel Immunomodulatory Bispecific Antibodies

GlobeNewswire November 9, 2016

Merus Announces Third Quarter 2016 Financial Results and Corporate Developments

GlobeNewswire November 7, 2016

Merus Strengthens Executive Management Team with the Appointment of John Crowley as Chief Financial Officer

GlobeNewswire November 3, 2016

Merus Expands Executive Management Team with the Appointment of L. Andres Sirulnik, MD, PhD, as Chief Medical Officer

GlobeNewswire October 26, 2016

Merus Receives Milestone Payment from Ono Pharmaceutical for Selection of Bispecific Antibody Candidate for Clinical Development and Extends Partnership with CMC Service Agreement

GlobeNewswire October 19, 2016

Merus to Participate in Upcoming Investor Conferences

GlobeNewswire August 31, 2016

Merus to Present at the 2016 Wedbush PacGrow Healthcare Conference

GlobeNewswire August 10, 2016

Merus Announces Second Quarter 2016 Financial Results and Reviews Recent Clinical Progress and Corporate Developments

GlobeNewswire August 8, 2016

Merus Announces First Quarter 2016 Financial Results and Highlights Recent Clinical Progress and Corporate Developments

GlobeNewswire July 12, 2016

The Market In 5 Minutes: Microsoft-LinkedIn, And Some Major iPhone News

Benzinga.com  June 13, 2016